Pre-Market Review: Alkermes PLC, Hospira Inc., Celsion Corp., and Theravance Inc. Editor Note: For more information about this release, please scroll to bottom PR Newswire LONDON, October 24, 2013 LONDON, October 24, 2013 /PRNewswire/ -- On Wednesday, October 23, 2013, the S&P 500 ended the day at 1,746.38, down 0.47%; the Dow Jones Industrial Average closed at 15,413.33, down 0.35%; and the NASDAQ Composite finished at 3,907.07, down 0.57%. Shares in the healthcare sector mostly ended on a lower note, as the broader market posted losses. The major movers in the sector include Alkermes PLC (NASDAQ: ALKS), Hospira Inc. (NYSE: HSP), Celsion Corporation (NASDAQ: CLSN), and Theravance Inc. (NASDAQ: THRX). AAAResearchReports.com initiated preliminary technical research on ALKS, HSP, CLSN, and THRX. These free reports are accessible by signing today at: http://www.aaaresearchreports.com/register/ Alkermes PLC's shares ended the day 0.66% lower at $34.72, after vacillating between $34.43 and $34.86. A total of 0.57 million shares were traded, which is below the daily average volume of 0.89 million. Despite Wednesday's pullback, the company's shares have gained 3.39% in the last one month and 17.66% in the past three months, outperforming the S&P 500, which has advanced 2.62% and 3.19% during the respective periods. Furthermore, Alkermes PLC's stock is trading near its 52-week high of $35.72 and above its 50-day and 200-day moving averages of $33.17 and $28.52, respectively. The free technical analysis on ALKS is available by signing up at: http://www.AAAResearchReports.com/ALKS102413.pdf Hospira Inc.'s stock closed the day at $41.30, down 0.72%, after oscillating between $41.20 and $41.55 during the trading session. A total of 0.52 million shares were traded, which is below the daily average volume of 0.71 million. Despite Wednesday's losses, the company's shares have gained 1.45% in the last one month and 4.58% in the previous three months, compared to a gain of 2.62% and 3.19% in the S&P 500 during the respective periods. Moreover, Hospira Inc.'s stock is trading near its 52-week high of $42.60 and above its 50-day and 200-day moving averages of $39.95 and $35.89, respectively. Register now to download free research on HSP at: http://www.AAAResearchReports.com/HSP102413.pdf Celsion Corp.'s stock ended flat on Wednesday, even as the broader traded posted losses. The company's shares closed the day at the previous day's closing price of $1.17, after oscillating between $1.15 and $1.18 during the trading session. A total of 0.55 million shares were traded, which is significantly below the daily average volume of 1.69 million. The company's shares have fallen by 0.85% in the last one month, underperforming the S&P 500, which has advanced 2.62% during the same period. Moreover, Celsion Corp.'s stock is trading below its 50-day and 200-day moving averages of $1.19 and $1.71, respectively. A free report on CLSN can be accessed by registering at: http://www.AAAResearchReports.com/CLSN102413.pdf On Wednesday, shares in Theravance Inc. fell by 0.61%, tracking losses in the broader market. The company's shares traded between $35.68 and $37.56 before finishing the day at $36.08. A total of 0.80 million shares were traded, which is less than the daily average volume of 0.83 million. Despite Wednesday's pullback, the company's shares have gained 5.59% in the previous three trading sessions, outperforming the S&P 500, which has advanced 0.11% during the same period. Moreover, Theravance Inc.'s stock is trading above its 200-day moving average of $32.14. Register with AAA Research Reports and download research on THRX for free at: http://www.AAAResearchReports.com/THRX102413.pdf ---- EDITOR NOTES: 1.This is not company news. We are an independent source and our views do not reflect the companies mentioned. 2.Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. 3.This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public. 4.If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com. 5.For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com. 6.Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration. COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be. NOT FINANCIAL ADVICE Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein. NO WARRANTY OR LIABILITY ASSUMED Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute. SOURCE AAA Research Reports Contact: Phone #: +1(646)396-9126, Contact Name: Peter F. Jones Email ID: firstname.lastname@example.org
Pre-Market Review: Alkermes PLC, Hospira Inc., Celsion Corp., and Theravance Inc.
Press spacebar to pause and continue. Press esc to stop.